Top Markets
Coin of the day
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

SPPI
Clasificación en acciones #21095
Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily... Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders. Its robust pipeline features Eflapegrastim, an advanced, long-acting granulocyte colony-stimulating factor designed to address chemotherapy-induced neutropenia. Also under development is Poziotinib, a distinct irreversible tyrosine kinase inhibitor intended for non-small cell lung cancer tumors exhibiting various mutations. Furthermore, Anti-CD20-IFNa, an antibody-interferon fusion molecule targeting CD20, is progressing through Phase I development for patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. The company maintains key collaborative agreements, such as co-development, commercialization, and in-licensing arrangements with Hanmi Pharmaceutical Co. Ltd., a patent and technology license with The University of Texas M.D. Anderson Cancer Center, and an in-license pact with ImmunGene, Inc. Founded in 1987, and initially known as NeoTherapeutics, Inc. before its name change in December 2002, Spectrum Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Precio por acción
$1.03
Última sincronización: 2023-07-31
Capitalización bursátil
$115.13M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Spectrum Pharmaceuticals, Inc. (SPPI)

Categoría

Historial del precio de la acción de Spectrum Pharmaceuticals, Inc. (SPPI)
Precio más alto de cierre: $0.98 el 2023-07-01

Precio más bajo de cierre: $146.88 el 1996-09-01
Historial del precio de la acción de Spectrum Pharmaceuticals, Inc. desde 1996 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 142.39%
2022 -72.40%
2021 -66.76%
2020 -45.64%
2019 -24.79%
2018 -42.30%
2017 324.76%
2016 -24.40%
2015 -18.21%
2014 -20.89%
2013 -20.68%
2012 -21.84%
2011 142.92%
2010 27.82%
2009 208.32%
2008 -48.89%
2007 -47.10%
2006 36.47%
2005 -30.49%
2004 -16.52%
2003 256.95%
2002 -97.89%
2001 -26.14%
2000 -57.96%
1999 39.74%
1998 -8.28%
1997 119.65%
1996 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH